Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsHowever, with global funding pledges falling short of the target required to sustain health programming, how can countries, including Indonesia, win their goal to end AIDS, tuberculosis and malaria as global health threats?
As the health system grapples with the unprecedented spread of misinformation, fueling vaccine hesitancy and eroding public trust in the government’s health programs, it is more critical than ever for the government to reinvest in the foundations of public health.
Some Indonesian netizens oppose the clinical trial of a tuberculosis (TB) vaccine candidate in Indonesia, whose development has been supported by the Gates Foundation. They claim that the state is selling people as "lab rats" for the philanthropist’s agenda.
The government has scaled up efforts against tuberculosis by empowering local communities and strengthening health facilities down to the village and subdistrict levels for the early detection and treatment of the world’s deadliest infectious disease.
The clinical trials for a tuberculosis (TB) vaccine candidate developed with funding from the Gates Foundation are taking place in Indonesia under close monitoring by multiple national and international institutions and researchers, according to the Health Ministry.
The US withdrawal from global health aid highlights the vulnerability of global health funding to geopolitical shifts, and serves as a wake-up call for Indonesia to build a self-reliant healthcare model that is capable of delivering integrated services, such as for TB, in anticipation of future uncertainties.
The West Java city of Bogor is expanding its efforts in both case detection and public outreach, specifically for groups at high risk of contracting tuberculosis, amid a surge in active cases in one of four TB hot spots in the province.